GSDME is cleaved and activated by caspase-3, similar to GSDMD by caspase-1/11 (5, 10, 16), and can switch caspase-3-driven apoptosis to pyroptosis, making cancer cells more sensitive to cytotoxic agents (17). Here, CASP3 is linked to cancer.